N-Hexanoic-Try-Ile-(6)-amino Hexanoic amide (Dihexa)
N-(1-Oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide; Dihexa; (2S,3S)-N-(6-amino-6-oxohexyl)-2-[[(2S)-2-(hexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanamide
Dihexa is a drug that belongs to the class of amides. It has been shown to have toxicological properties in cell culture experiments and animal studies. Dihexa is an inhibitor of p450, which is an enzyme that catalyzes the conversion of fatty acids into eicosanoids, such as prostaglandins, leukotrienes, and thromboxanes. These molecules are important mediators of inflammation, immune response, and blood clotting. This drug also inhibits growth factor activity and may be used in the treatment of autoimmune diseases. Dihexa has been shown to inhibit melanoma antigen and infectious disease cells by binding to copper ions with microbicidal activity. The molecule also binds platinum-based chemotherapy drugs with hepatocyte-like cells to form a complex that leads to apoptosis or cell death by necrosis.
Synonyms
N-(1-Oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide; Dihexa; (2S,3S)-N-(6-amino-6-oxohexyl)-2-[[(2S)-2-(hexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanamide
Molecular Formula
C₂₇H₄₄N₄O₅
Appearance
White to off-white solid
1H-NMR
Conforms to reference
Melting Point
>209°C (dec.)
Solubility
DMSO (Slightly), Methanol (Slightly)
Storage and Stability
May be stored at RT for short-term only. Long-term storage is recommended at -4C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards
All products should be handled by qualified personnel only, trained in laboratory procedures.
